Digestive Enzyme Supplements Market to Reach USD 3.5 Billion by 2033: Growth Fueled by Rising Demand and Therapeutic Innovations

The digestive enzyme supplements market size is projected to be valued at US$ 1.9 Bn in 2023 and is expected to rise to US$ 3.5 Bn by 2033. The sales of digestive enzyme supplements are expected to grow at a significant CAGR of 6.1% during the forecast period.

Digestive enzyme supplements have emerged as a reliable adjuvant in the treatment of gastrointestinal disorders and other disorders caused by or characterized by mild to severe digestive function impairment.

A variety of digestive problems, including lactose intolerance, cystic fibrosis, and exocrine pancreatic insufficiency, can be effectively treated with various formulations of digestive enzyme supplements that are readily accessible in the market.

New formulations based on plant- and microbe-derived enzymes have been discovered as a result of recent advancements in therapeutics, and they hold tremendous promise for the development of the worldwide digestive enzyme supplement market.

Request Sample Report and Drive Impactful Decisions: https://www.futuremarketinsights.com/reports/sample/rep-gb-11225

Key Takeaways from the Digestive Enzyme Supplements

• The digestive supplement market in the US is expanding at a rate of 5.2% as a result of important product launches, increased research activity and a high concentration of manufacturers or market players, in the country.
• With a revenue share of USD 113.5mn, U.K has contributed a sizeable share in the global market. The growing online sales channel and expansion of sports nutrition is proliferating market growth.
• Currently, China holds dominance with a growth rate of 7.1% in Asia Pacific region. The high prevalence of chronic disorders had let regulating authorities to initiate various awareness programs which highly includes the incorporation of digestive support.
• Animal derived segments dominates the market and would expand substanitialy at a CAGR of 4.9%. Increases in gastrointestinal illnesses are predicted to have a favourable effect on the segment’s growth because animal-derived digestive enzymes are one of the most effective treatments for these conditions.
• Due to the increased frequency of digestive problems globally and the adoption of conventional ways for the disease’s care, conventional dietary supplements will grow exponentialy at a rate of 5.6%.
• Due to rising public awareness of fitness and wellbeing, the sports nutrition industry is expected to develop at the highest pace of 9.4%. Increase in sporting events and activities will further expand market reach.

Competitive Landscape

Due to the existence of several businesses operating both internationally and regionally, the digestive enzymes market is fragmented in character. A few well-known, internationally operating as well as domestically based businesses are examined in the competitive landscape, including Zeus Biotech Limited, Klaire Labs, Amway Corporation, AbbVie Inc., and Biotics Research Corporation, among others.

Gain Immediate Access to Detailed Market Insights Purchase Now: https://www.futuremarketinsights.com/checkout/11225

Latest Developments

• The University of Illinois at Urbana-Champaign will host a clinical trial in February 2022 that Bio-Cat Inc. is funding to examine the effectiveness of a digestive enzyme combination designed to enhance protein digestion and gastrointestinal tolerance.
• Mimi’s Rock Corp. announced in February 2022 that its supplements brand, Dr. Tobias, is extending the range of products it offers by adding digestive enzymes, prebiotics, and probiotics to support gut health. This move is being made in response to the rising demand for products in the digestive health sector.

Key Segments Covered in the Digestive Enzyme Supplements Market Report

By Origin:

• Animal
• Plant
• Microbial

By Application:

• Additional supplements
• Medical & infant nutrition
• Sports Nutrition

By Type:

• Carbohydrase
• Protease
• Lipase
• Other Enzyme Types

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan (APEJ)
• Japan
• Middle East & Africa (MEA)

Authored by:

Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.) has 7+ years of management consulting experience. She advises industry leaders and explores off-the-eye opportunities and challenges. She puts processes and operating models in place to support their business objectives.

She has exceptional analytical skills and often brings thought leadership to the table.

Nandini has vast functional expertise in key niches, including but not limited to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results.

Her core expertise lies in corporate growth strategy, sales and marketing effectiveness, acquisitions and post-merger integration and cost reduction. Nandini has an MBA in Finance from MIT School of Business. She also holds a Bachelor’s Degree in Electrical Engineering from Nagpur University, India.

Nandini has authored several publications, and quoted in journals including Beverage Industry, Bloomberg, and Wine Industry Advisor.

Explore FMI’s related ongoing Coverage in Food and Beverage Domain:

The multi nutritional supplement market was worth US$ 310 Billion in 2020 and is expected to advance at a 5.9% CAGR from 2022 to 2032.

The fertility supplements market is expected to witness a prominent growth rate of a CAGR of 8.3% to reach the value of US$ 4,382 Mn in 2031.

The global calcium supplements market is forecasted to be valued at US$ 8.01 billion by 2032, up from US$ 3.8 billion in 2022, advancing at a CAGR of 7.74% from 2022 to 2032.

The older adults health supplements market is projected to register a CAGR of 6% during the forecast period, up from US$ 140 Bn in 2021 to reach a valuation of US$ 265 Bn by 2032.

The global liver health supplements market size is set to exhibit growth at a CAGR of 5.6% in the forecast period. It is anticipated to be valued at US$ 9.4 Billion in 2022 and US$ 14.7 Billion in 2032.

The overall demand for green supplements is projected to grow at a CAGR of 3.8 %, reaching around US$ 818.0 Million by 2032.

The Glucosamine Supplements Market is expected to expand at a CAGR of 4.8%. The industry’s estimated value will increase from US$ 583.6 Million in 2023 to US$ 932.7 Million in 2033.

The consumption of dietary supplement in Western Europe is estimated to expand at a promising CAGR of 8.2% through 2033.

The gut health supplement sales are projected to grow at 8.3% CAGR, taking the overall market valuation to US$ 27,312.0 million by 2033.

The algae-based supplement market size is expected to expand from US$ 2,365.3 million in 2024 to US$ 4,804.5 million by 2034.

The global L-carnitine supplements market is projected to surpass US$ 386 million by the end of 2033, in terms of revenue. The market is projected to register a CAGR of 6% during the forecast period

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube